Published in BMC Pregnancy Childbirth on February 05, 2013
Prevention and management of severe pre-eclampsia/eclampsia in Afghanistan. BMC Pregnancy Childbirth (2013) 0.95
Contemporary clinical management of the cerebral complications of preeclampsia. Obstet Gynecol Int (2013) 0.82
Situational analysis of facilitators and barriers to availability and utilization of magnesium sulfate for eclampsia and severe preeclampsia in the public health system in Brazil. BMC Pregnancy Childbirth (2016) 0.78
Magnesium sulphate versus phenytoin in eclampsia - Maternal and foetal outcome - A comparative study. Australas Med J (2013) 0.78
The Role of Magnesium in the Pathogenesis and Treatment of Glaucoma. Int Sch Res Notices (2014) 0.75
Magnesium in obstetric anesthesia and intensive care. J Anesth (2016) 0.75
WHO analysis of causes of maternal death: a systematic review. Lancet (2006) 20.24
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet (2002) 10.48
Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet (1995) 9.50
Pre-eclampsia. Lancet (2010) 7.46
The global impact of pre-eclampsia and eclampsia. Semin Perinatol (2009) 5.50
The integrative review: updated methodology. J Adv Nurs (2005) 4.12
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med (2003) 4.04
Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol (1992) 3.64
A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol (1998) 2.86
Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Serv Res (2005) 2.50
Evidence-based reproductive health care in Cameroon: population-based study of awareness, use and barriers. Bull World Health Organ (2006) 2.19
Maternal mortality from preeclampsia/eclampsia. Semin Perinatol (2012) 1.88
Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy. J Obstet Gynaecol Res (2007) 1.58
Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke (2009) 1.52
Magnesium sulphate versus diazepam in the management of eclampsia: a randomized controlled trial. Br J Obstet Gynaecol (1990) 1.48
Pre-eclampsia in low and middle income countries. Best Pract Res Clin Obstet Gynaecol (2011) 1.38
The use of the magnesium ion in the management of eclamptogenic toxemias. Surg Gynecol Obstet (1955) 1.29
Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia. BMC Health Serv Res (2010) 1.22
Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One (2012) 1.19
The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia. Ann Afr Med (2009) 1.12
Maternal deaths due to eclampsia and HELLP syndrome. Int J Gynaecol Obstet (2008) 1.10
Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles. Clin Pharmacokinet (2000) 1.10
Treatment approaches for preeclampsia in low-resource settings: A randomized trial of the Springfusor pump for delivery of magnesium sulfate. Pregnancy Hypertens (2011) 1.02
A low dose ("Dhaka") magnesium sulphate regime for eclampsia. Acta Obstet Gynecol Scand (2001) 0.92
The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success? Hypertens Pregnancy (2003) 0.91
Low-dose magnesium sulfate versus Pritchard regimen for the treatment of eclampsia imminent eclampsia. Int J Gynaecol Obstet (2011) 0.89
'Padhar regime' - a low-dose magnesium sulphate treatment for eclampsia. Gynecol Obstet Invest (2008) 0.88
Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database Syst Rev (2010) 0.88
A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use. Int J Gynaecol Obstet (2012) 0.87
Is serum magnesium estimate necessary in patients with eclampsia on magnesium sulphate? Afr J Reprod Health (2005) 0.86
Safety and efficacy of low-dose MgSO4 in the treatment of eclampsia. Int J Gynaecol Obstet (2007) 0.86
Intravenous and intramuscular magnesium sulphate regimens in severe pre-eclampsia. S Afr Med J (1994) 0.84
A comparison of serum magnesium sulfate levels in pregnant women with severe preeclampsia between intravenous and intramuscular magnesium sulfate regimens: a randomized controlled trial. J Med Assoc Thai (1996) 0.84
Serum level of magnesium attained in magnesium sulfate therapy for severe preeclampsia. Asia Oceania J Obstet Gynaecol (1993) 0.84
Predictors of extra care among magnesium sulphate treated eclamptic patients at Muhimbili National Hospital, Tanzania. BMC Pregnancy Childbirth (2011) 0.84
Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate regimen for treatment of eclampsia. J Obstet Gynaecol Res (2009) 0.83
Magnesium sulfate: past, present, and future. J Midwifery Womens Health (2011) 0.82
Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia in 3 Indian hospitals. Int J Gynaecol Obstet (2011) 0.81
Preliminary report on the use of magnesium sulfate in cases of severe pre-eclampsia and eclampsia. J Postgrad Med (1985) 0.80
Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol (1990) 0.80
Magnesium sulphate for treatment of eclampsia: the Nigerian experience. Afr J Med Med Sci (2001) 0.80
Loading dose of magnesium sulphate versus standard regime for prophylaxis of pre-eclampsia. J Coll Physicians Surg Pak (2009) 0.80
A randomised comparative study between low-dose intravenous magnesium sulphate and standard intramuscular regimen for treatment of eclampsia. J Obstet Gynaecol (2011) 0.79
A safer and more effective treatment regimen for eclampsia. Aust N Z J Obstet Gynaecol (1994) 0.79
Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol (1966) 0.78
Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait. Med Princ Pract (2008) 0.78
Prediction of maternal and fetal complications in preeclampsia. Acta Obstet Gynecol Scand (2000) 0.77
Can postgraduate courses in Maternal-Fetal Medicine change clinical attitude? J Matern Fetal Neonatal Med (2005) 0.77
Characteristics of preeclampsia- and eclampsia-related maternal death in rural Haiti. J Matern Fetal Neonatal Med (2005) 0.77
Efficacy and safety of magnesium sulphate (MgSO4) in the treatment of eclampsia. J Indian Med Assoc (2011) 0.76
Medication safety in obstetrics and gynecology. Clin Obstet Gynecol (2010) 0.76
Recruitment of hard-to-reach population subgroups via adaptations of the snowball sampling strategy. Nurs Health Sci (2010) 2.01
Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date. BMC Pregnancy Childbirth (2013) 1.66
Maternal and perinatal health research priorities beyond 2015: an international survey and prioritization exercise. Reprod Health (2014) 1.61
Effective in-service training design and delivery: evidence from an integrative literature review. Hum Resour Health (2013) 1.23
Outcomes, safety, and resource utilization in a collaborative care birth center program compared with traditional physician-based perinatal care. Am J Public Health (2003) 1.17
Pragmatic strategies that enhance the reliability of data abstracted from medical records. Appl Nurs Res (2005) 1.06
Factors influencing health care-seeking behaviours among Mayan women in Guatemala. Midwifery (2007) 1.05
The interrelationship of maternal stress, endocrine factors and inflammation on gestational length. Obstet Gynecol Surv (2003) 1.05
Predicting risk of preterm birth: the roles of stress, clinical risk factors, and corticotropin-releasing hormone. Biol Res Nurs (2002) 1.00
Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists. J Med Chem (2005) 0.87
An integrative review and evidence-based conceptual model of the essential components of pre-service education. Hum Resour Health (2013) 0.84
Cord clamping and active management of the third stage. J Midwifery Womens Health (2007) 0.79
Sample size considerations when groups are the appropriate unit of analysis. Appl Nurs Res (2007) 0.79
The utility of fFN for the prediction of preterm birth in twin gestations. J Obstet Gynecol Neonatal Nurs (2004) 0.79
Assessing impact and sustainability of health, water, and sanitation interventions in Bolivia six years post-project. Rev Panam Salud Publica (2012) 0.78
Findings from the analysis of the American College of Nurse-Midwives' membership surveys: 2000-2003. J Midwifery Womens Health (2005) 0.77
The 1999-2000 task analysis of American nurse-midwifery/midwifery practice. J Midwifery Womens Health (2002) 0.75
Findings from the analysis of the American College of Nurse-Midwives' membership surveys: 2006-2008. J Midwifery Womens Health (2010) 0.75
Findings from the analysis of the American College of Nurse-Midwives' membership surveys: 2009 to 2011. J Midwifery Womens Health (2013) 0.75
The Midwifery Workforce: ACNM 2012 and AMCB 2013 Core Data. J Midwifery Womens Health (2015) 0.75
Creating a Novel Online Digital Badge-Awarding Program in Patient Navigation to Address Healthcare Access. J Nurses Prof Dev (2017) 0.75
Learning Style of Undergraduate Allied Health Students: clinical versus classroom. J Allied Health (2013) 0.75